Reduced EF (LVEF≤40%) | Preserved EF (LVEF>40%) | |||
---|---|---|---|---|
Variable | Adjusted HR (95% CI) | p Value | Adjusted HR (95% CI) | p Value |
Male | 1.77 (1.18 to 2.65) | <0.01 | 0.96 (0.73 to 1.27) | 0.80 |
Age (per 10 years) | 1.73 (1.44 to 2.07) | <0.01 | 1.71 (1.46 to 2.00) | <0.01 |
High β-blocker dose | 1.17 (0.83 to 1.766) | 0.37 | 0.82 (0.62 to 1.08) | 0.16 |
Low heart rate (<70 bpm) | 0.99 (0.70 to 1.41) | 0.96 | 0.90 (0.68 to 1.19) | 0.45 |
Previous MI | — | — | 1.51 (1.11 to 2.06) | <0.01 |
COPD | 1.47 (1.02 to 2.12) | 0.04 | 1.61 (1.21 to 2.13) | <0.01 |
Dyslipidaemia (per mmol/L) | 1.72 (1.21 to 2.44) | <0.01 | — | — |
Haemoglobin (per g/L) | 0.98 (0.97 to 0.99) | <0.01 | 0.99 (0.98 to 0.99) | <0.01 |
WCC (per 10^9/L) | 1.09 (1.03 to 1.16) | <0.01 | 1.07 (1.03 to 1.11) | <0.01 |
Variable excluded from final model due to non-significance.
HRs for laboratory data and heart rate represent a change in one unit.
COPD, chronic obstructive pulmonary disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; WCC, white cell count.